Goldman Sachs’s STAAR Surgical STAA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-7,000
Closed -$246K 5548
2019
Q4
$246K Sell
7,000
-82,100
-92% -$2.71M ﹤0.01% 4827
2019
Q3
$2.3M Buy
+89,100
New +$2.71M ﹤0.01% 3442
2014
Q3
Sell
-174,000
Closed -$2.92M 7253
2014
Q2
$2.92M Sell
174,000
-528,500
-75% -$8.69M ﹤0.01% 3616
2014
Q1
$13.2M Buy
702,500
+489,200
+229% +$7.88M ﹤0.01% 2120
2013
Q4
$3.45M Buy
+213,300
New +$2.85M ﹤0.01% 3496

Other funds holding STAA

Goldman Sachs's STAA Position: Q2 2026 in Review

Goldman Sachs increased its STAAR Surgical (STAA) stake by 101% in Q2 2026, buying an estimated $30M and bringing the position to 2,150,809 shares worth $61.7M. The position accounts for 0.01% of the portfolio, ranked #1628.

Goldman Sachs first reported a position in STAA in Q2 2013 and has held it in 49 quarters since. 201 funds tracked by Wall St. Rank hold STAA as of Q2 2026.

  • Goldman Sachs held 2,150,809 shares of STAAR Surgical worth $61.7M as of Q2 2026.
  • Goldman Sachs bought 1,080,870 STAAR Surgical shares in Q2 2026, an estimated $30M.
  • STAAR Surgical made up 0.01% of Goldman Sachs's portfolio in Q2 2026, its #1628 holding.
  • Goldman Sachs first reported a position in STAAR Surgical in Q2 2013 and has held it in 49 quarters since.
  • 201 funds tracked by Wall St. Rank held STAAR Surgical as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.